American CryoStem Corporation   Report issue

For profit Phase 1
Founded: Eatontown NJ United States (2008)

Organization Overview

First Clinical Trial
2014
NCT02326935
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

American CryoStem Corporation